Healthcare seed funding share drops 3pp while AI & Data rises 3.6pp in France and Netherlands
- Healthcare & Life Sciences seed share fell 3 percentage points from 2021 to 2024
- Artificial Intelligence & Data seed share rose 3.6 percentage points over the same period
- Healthcare median seed round (€10.3M) remains slightly above AI median (€9.6M)
Across the 1,500 seed-stage deals Brouky tracks in France and the Netherlands, Healthcare & Life Sciences experienced the largest decline in funding share between 2021 and 2024, dropping 3 percentage points from 14.9% to 11.9%. This contraction contrasts with the growth of the Artificial Intelligence & Data sector, which gained 3.6 percentage points, increasing its share from 8.6% to 12.2%. This may partly reflect expanding data coverage.
Despite losing share, Healthcare rounds maintain a higher median size of €10,295,872 compared to AI & Data's median of €9,587,156, indicating sustained investor confidence in later-stage capital intensity within healthcare.
Other sectors such as Software & Developer Tools also showed notable gains (+10.8pp), but the most direct substitution observed is between Healthcare's retreat and AI & Data's rise. This reflects evolving investor priorities in early-stage ventures within these two countries.
Related insights
- Cross-Country AnalysisFrance’s early-stage startups show a higher single-round funding share than the UK
- Cross-Country AnalysisHealthcare's 1pp seed funding share drop contrasts with Energy's 3.6pp rise
- Deal SpotlightGuoce Quantum raises EUR65M in Series B backed by six investors
- Deal SpotlightHoliday Tribe raises EUR5.5M Seed backed by RPSG Capital Ventures
Explore the full dataset
Brouky tracks 37,000+ investors and 122,000+ investments across 134,000+ startups. Search by country, stage, and sector.